About Metreleptin
            
            Class: | Hormone replacement therapy (leptin analog)  
Use: | Treatment of leptin deficiency in patients with congenital or acquired generalized lipodystrophy  
Adult dose: | Initial dose of 0.06 mg/kg subcutaneously once daily; may be adjusted based on clinical response and tolerability  
Pediatric dose: | Initial dose of 0.06 mg/kg subcutaneously once daily for children aged 2 years and older; adjustments may be made based on clinical response  
Side effects: | Hypoglycemia, injection site rea
         
        
            
                
                
                    
                        Drug Class
                    
                    Hormone replacement therapy (leptin analog)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of leptin deficiency in patients with congenital or acquired generalized lipodystrophy
                 
                
                
                    
                        Storage Requirements
                    
                    Store lyophilized powder at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light; after reconstitution, use within 3 hours if stored at room temperature or within 24 hours if refrigerated
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Amryt Pharma Group, United States of America
                    
                    
                    Package Size
                    Vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 14429.40
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose of 0.06 mg/kg subcutaneously once daily; may be adjusted based on clinical response and tolerability
                    
                    
                        Pediatric Dose
                    
                    
                        Initial dose of 0.06 mg/kg subcutaneously once daily for children aged 2 years and older; adjustments may be made based on clinical response
                    
                 
                
                
                    
                        Side Effects
                    
                    Hypoglycemia, injection site reactions, headache, abdominal pain, nausea, and increased liver enzymes
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Known hypersensitivity to metreleptin or any component of the formulation; caution in patients with a history of hypersensitivity reactions
         
        
        
            
                Important Warnings
            
            Risk of serious infections; monitor for signs of pancreatitis; may cause hypoglycemia; not a substitute for insulin in patients with diabetes; potential for development of anti-metreleptin antibodies
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.